Yanqun Dong

Fox Chase Cancer Center

Papers

1

Total Citations

28

H-Index

1

About

Dr. Yanqun Dong is a leading researcher in radiation oncology, with a primary focus on the optimization of stereotactic body radiation therapy (SBRT) for the treatment of prostate cancer. His most cited work, a 2016 study comparing robotic arm versus gantry linear accelerator SBRT, represents a pivotal contribution to the field. This research directly addresses the critical need for precise, efficient treatment delivery for the most prevalent non-skin cancer in American men. By systematically analyzing the dosimetric and clinical outcomes of these two advanced platforms, Dr. Dong’s work provides essential guidance for clinicians selecting the optimal technology to deliver high-dose, hypofractionated radiation (6-15 Gy per fraction) over a condensed two-week schedule. His comparative analysis helps to balance treatment accuracy, patient convenience, and clinical efficacy, directly impacting the standard of care. With his work accumulating significant citations, Dr. Dong is recognized for his rigorous, evidence-based approach to improving therapeutic ratios and patient outcomes in modern radiation oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
28
Total Citations
28
Avg Citations/Paper
🏆 Most Cited Paper
A comparison of robotic arm versus gantry linear accelerator stereotactic body radiation therapy for prostate cancer
28 citations · 2016
📈 Most Prolific Year: 2016 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Fox Chase Cancer Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 10 days ago